SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following?
MEDX 31.14-0.1%Oct 30 10:04 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tom pope who wrote (2177)6/23/2009 2:43:42 PM
From: tuck  Read Replies (4) of 2240
 
Well, the skepticism is based on lack of detail about the trial. The number of total patients, the randomization ratio, stuff like that. Hard to answer the "was it the ablation, the antibody, or the combo" question at this point. Here's the release from Mayo:

mayoclinic.org

Posted for all the second graders out there. Maybe Lowe adds little here, but I don't think "cheap shot" is fair, either. The PR is hype -- possibly justified, but too soon to say -- without the numbers to back it up.

Look, my Mom is a long time holder of MEDX, I want them to succeed, too.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext